Evolva Holding, Emergent BioSolutions deal

Emergent acquired Evolva’s EV-035 antibiotic portfolio, including preclinical melioidosis candidate GC-072. The U.S. Department of Defense’s Defense Threat Reduction Agency is funding preclinical de...